Association of serum uric acid concentration with diabetic retinopathy and albuminuria in Taiwanese patients with type 2 diabetes mellitus

International Journal of Molecular Sciences

Volumn 17, Issue 8, 2016, Pages

  Liang, Ching Chao ^a   Lin, Pi Chen ^b   Lee, Mei Yueh ^b,c,d   Chen, Szu Chia ^b,c,d   Shin, Shyi Jang ^b,d,e   Hsiao, Pi Jung ^b,d   Lin, Kun Der ^b,d,f   Hsu, Wei Hao ^b,c  

^a Kaohsiung Municipal Cijin Hospital   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

Author keywords

Albuminuria; Diabetes mellitus; Diabetic nephropathy; Diabetic retinopathy; Uric acid

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; CREATININE;

ADULT; ALBUMINURIA; ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; AGED; BLOOD; COMPLICATION; RISK FACTOR; STATISTICAL MODEL; TAIWAN; URINE;

AGED; ALBUMINURIA; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; TAIWAN; URIC ACID;

EID: 84982676380     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17081248     Document Type: Article

References (25)

1. Fong, D.S.; Aiello, L.P.; Ferris, F.L., 3rd; Klein, R. Diabetic retinopathy. Diabetes Care 2004, 27, 2540–2553. [CrossRef] [PubMed]
2. Sivaprasad, S.; Gupta, B.; Crosby-Nwaobi, R.; Evans, J. Prevalence of diabetic retinopathy in various ethnic groups: A worldwide perspective. Surv. Ophthalmol. 2012, 57, 347–370. [CrossRef] [PubMed]
3. Ritz, E.; Orth, S.R. Nephropathy in patients with type 2 diabetes mellitus. N. Engl. J. Med. 1999, 341, 1127–1133. [CrossRef] [PubMed]
4. Hwang, S.J.; Tsai, J.C.; Chen, H.C. Epidemiology, impact and preventive care of chronic kidney disease in taiwan. Nephrology 2010, 15 (Suppl. 2), 3–9. [CrossRef] [PubMed]
5. Lee, J.J.; Yang, I.H.; Kuo, H.K.; Chung, M.S.; Chen, Y.J.; Chen, C.H.; Liu, R.T. Serum uric acid concentration is associated with worsening in severity of diabetic retinopathy among type 2 diabetic patients in taiwan—A 3-year prospective study. Diabetes Res. Clin. Pract. 2014, 106, 366–372. [CrossRef] [PubMed]
6. Fukui, M.; Tanaka, M.; Shiraishi, E.; Harusato, I.; Hosoda, H.; Asano, M.; Kadono, M.; Hasegawa, G.; Yoshikawa, T.; Nakamura, N. Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism 2008, 57, 625–629. [CrossRef] [PubMed]
7. Fu, C.C.; Wu, D.A.; Wang, J.H.; Yang, W.C.; Tseng, C.H. Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients. Acta Diabetol. 2009, 46, 127–134. [CrossRef] [PubMed]
8. Cai, X.L.; Wang, F.; Ji, L.N. Risk factors of diabetic retinopathy in type 2 diabetic patients. Chin. Med. J. 2006, 119, 822–826. [PubMed]
9. Krizova, L.; Kalousova, M.; Kubena, A.; Benakova, H.; Zima, T.; Kovarik, Z.; Kalvoda, J.; Kalvodova, B. Increased uric acid and glucose concentrations in vitreous and serum of patients with diabetic macular oedema. Ophthalmic Res. 2011, 46, 73–79. [CrossRef] [PubMed]
10. Krizova, L.; Kalousova, M.; Kubena, A.A.; Chrapek, O.; Chrapkova, B.; Sin, M.; Zima, T. Correlation of vitreous vascular endothelial growth factor and uric acid concentration using optical coherence tomography in diabetic macular edema. J. Ophthalmol. 2015, 2015. [CrossRef] [PubMed]
11. Aiello, L.P.; Avery, R.L.; Arrigg, P.G.; Keyt, B.A.; Jampel, H.D.; Shah, S.T.; Pasquale, L.R.; Thieme, H.; Iwamoto, M.A.; Park, J.E. et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 1994, 331, 1480–1487. [CrossRef] [PubMed]
12. Selim, K.M.; Sahan, D.; Muhittin, T.; Osman, C.; Mustafa, O. Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy. Indian J. Ophthalmol. 2010, 58, 375–379. [CrossRef] [PubMed]
13. Funatsu, H.; Yamashita, H.; Noma, H.; Mimura, T.; Nakamura, S.; Sakata, K.; Hori, S. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefe’s Arch. Clin. Exp. 2005, 243, 3–8. [CrossRef] [PubMed]
14. Hovind, P.; Rossing, P.; Tarnow, L.; Johnson, R.J.; Parving, H.H. Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: An inception cohort study. Diabetes 2009, 58, 1668–1671. [CrossRef] [PubMed]
15. Hayashino, Y.; Okamura, S.; Tsujii, S.; Ishii, H. Association of serum uric acid levels with the risk of development or progression of albuminuria among Japanese patients with type 2 diabetes: A prospective cohort study [Diabetes Distress And Care Registry at Tenri (DDCRT 10)]. Acta Diabetol. 2016. [CrossRef] [PubMed]
16. Papanas, N.; Katsiki, N.; Papatheodorou, K.; Demetriou, M.; Papazoglou, D.; Gioka, T.; Maltezos, E. Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus. Angiology 2011, 62, 291–295. [CrossRef] [PubMed]
17. Kiani, J.; Habibi, Z.; Tajziehchi, A.; Moghimbeigi, A.; Dehghan, A.; Azizkhani, H. Association between serum uric acid level and diabetic peripheral neuropathy (a case control study). Casp. J. Intern. Med. 2014, 5, 17–21.
18. Yu, S.; Chen, Y.; Hou, X.; Xu, D.; Che, K.; Li, C.; Yan, S.; Wang, Y.; Wang, B. Serum uric acid levels and diabetic peripheral neuropathy in type 2 diabetes: A systematic review and meta-analysis. Mol. Neurobiol. 2016, 53, 1045–1051. [CrossRef] [PubMed]
19. Mene, P.; Punzo, G. Uric acid: Bystander or culprit in hypertension and progressive renal disease? J. Hypertens. 2008, 26, 2085–2092. [CrossRef] [PubMed]
20. Oh, J.; Won, H.Y.; Kang, S.M. Uric acid and cardiovascular risk. N. Engl. J. Med. 2009, 360, 539–540. [PubMed]
21. Momeni, A.; Shahidi, S.; Seirafian, S.; Taheri, S.; Kheiri, S. Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients. Iran. J. Kidney Dis. 2010, 4, 128–132. [PubMed]
22. Bose, B.; Badve, S.V.; Hiremath, S.S.; Boudville, N.; Brown, F.G.; Cass, A.; de Zoysa, J.R.; Fassett, R.G.; Faull, R.; Harris, D.C. et al. Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis. Nephrol. Dial. Transplant. 2014, 29, 406–413. [CrossRef] [PubMed]
23. David, Z.I. Cherney. The Effect of Uric Acid Lowering in Type 1 Diabetes. Available online: https://clinicaltrials.gov/ct2/show/NCT02344602 (accessed on 23 June 2016).
24. Kato, S.; Ando, M.; Mizukoshi, T.; Nagata, T.; Katsuno, T.; Kosugi, T.; Tsuboi, N.; Maruyama, S. Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study). Nagoya J. Med.Sci. 2016, 78, 135–142. [PubMed]
25. Levey, A.S.; Coresh, J.; Balk, E.; Kausz, A.T.; Levin, A.; Steffes, M.W.; Hogg, R.J.; Perrone, R.D.; Lau, J.; Eknoyan, G. National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann. Intern. Med. 2003, 139, 137–147. [CrossRef] [PubMed]